Live Breaking News & Updates on Clone Pharmaceuticals|Page 4

Stay updated with breaking news from Clone pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae. ....

United States , Chong Zhao , Christine Ann Miller , Maurizio Luongo , Menarini Asia Pacific , Sciclone Pharmaceuticals Holdings Limited , Sourcea Menarini Asia Pacific Holdings Pte , World Health Organization , China Antimicrobial Surveillance Network , Sciclone Pharmaceuticals Holdings , European Union , Menarini Group , Sciclone Pharmaceuticals , Prnewswirea Menarini Asia Pacific Holdings Pte , Melinta Therapeutics , Menarini Asia Pacific Holdings , Chief Executive Officer , License Agreement , Independent States , Clone Pharmaceuticals , Cidara Therapeutics , Asia Pacific Holdings , A Menarini Asia Pacific Holdings Pte Ltd ,

CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE

/PRNewswire/ Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2021 financial results and. ....

Puerto Rico , United States , Cumberland Vibativ , Stephen Southworth , Life Sciences Center , Drug Administration , Verity Pharmaceuticals , Cumberland Emerging Technologies Inc , Small Business Administration , Cumberland Pharmaceuticals Inc , Vanderbilt Medical Center , Prnewswire Cumberland Pharmaceuticals Inc , Sciclone Pharmaceuticals , Cumberland Pharmaceuticals , Vanderbilt University , Kyowa Kirin , Clone Pharmaceuticals , Duchenne Muscular Dystrophy , Systemic Sclerosis , Aspirin Exacerbated Respiratory Disease , Sustainability Report , Watch Safety Alerts , Human Medical Products , Adverse Event Reporting System , Cumberland Emerging Technologies , Emerging Technologies ,

CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE

/PRNewswire/ Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2021 financial results and. ....

Puerto Rico , United States , Cumberland Vibativ , Stephen Southworth , Life Sciences Center , Drug Administration , Verity Pharmaceuticals , Cumberland Emerging Technologies Inc , Small Business Administration , Cumberland Pharmaceuticals Inc , Vanderbilt Medical Center , Prnewswire Cumberland Pharmaceuticals Inc , Sciclone Pharmaceuticals , Cumberland Pharmaceuticals , Vanderbilt University , Kyowa Kirin , Clone Pharmaceuticals , Duchenne Muscular Dystrophy , Systemic Sclerosis , Aspirin Exacerbated Respiratory Disease , Sustainability Report , Watch Safety Alerts , Human Medical Products , Adverse Event Reporting System , Cumberland Emerging Technologies , Emerging Technologies ,

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
News provided by
Share this article
Share this article
SHANGHAI, March 3, 2021 /PRNewswire/ SciClone Pharmaceuticals (Holdings) Limited ( SciClone Pharmaceuticals or SciClone ) was officially listed today on the Main Board of The Stock Exchange of Hong Kong Limited ( Hong Kong Stock Exchange or HKEx ) under stock code: 6600.
In the initial offering, the 11,599,000 shares offered for subscription in the Hong Kong Public Offering was oversubscribed by 1,068.05 times. The Offer Price was HK$18.80 per Offer Share, and the Global Offering has raised a total amount of HK$2,039.5 million in net proceeds (after deducting underwriting fees and commissions paid and payable in connection with the global offering and estimated expenses and assuming the Over-allotment Option is not exercised). ....

Hong Kong , Zhao Hong , Li Zhenfu , Medicines Company , Sciclone Pharmaceuticals , Gl Capital Group , Clone Pharmaceuticals , Main Board , Stock Exchange , Hong Kong Limited , Kong Stock , Hong Kong Public Offering , Offer Price , Offer Share , Global Offering , Over Allotment Option , Executive Director , Chief Executive Officer , ஹாங் காங் , ழோ ஹாங் , மருந்துகள் நிறுவனம் , க்ல் மூலதனம் குழு , குளோன் மருந்துகள் , பிரதான பலகை , ஸ்டாக் பரிமாற்றம் , ஹாங் காங் வரையறுக்கப்பட்டவை ,

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange
globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Zhao Hong , Li Zhenfu , Sciclone Pharmaceuticals Holdings , Medicines Company , Sciclone Pharmaceuticals , Gl Capital Group , Main Board , Stock Exchange , Hong Kong Limited , Kong Stock , Hong Kong Public Offering , Offer Price , Offer Share , Global Offering , Over Allotment Option , Executive Director , Chief Executive Officer , Clone Pharmaceuticals , ஹாங் காங் , ழோ ஹாங் , மருந்துகள் நிறுவனம் , க்ல் மூலதனம் குழு , பிரதான பலகை , ஸ்டாக் பரிமாற்றம் , ஹாங் காங் வரையறுக்கப்பட்டவை ,